basal insulin

Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win
Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win
Fierce Biotech
Novo Nordisk
FDA
diabetes
insulin
basal insulin
Icodec
Flag link:
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Flag link:
Novo Basal Insulin Gets CHMP Nod to Update Label
Novo Basal Insulin Gets CHMP Nod to Update Label
Investopedia
Novo Nordisk
basal insulin
diabetes
CHMP
Tresiba
Flag link:
Eli Lilly wins label expansion for Trulicity injection with basal insulin
Eli Lilly wins label expansion for Trulicity injection with basal insulin
Endpoints
Eli Lilly
Trulicity
basal insulin
diabetes
Flag link:
Lilly stops development of diabetes treatment
Lilly stops development of diabetes treatment
Yahoo/Reuters
Eli Lilly
diabetes
Peglispro
basal insulin
Flag link:
Lilly says peglispro is superior to Sanofi's Lantus
Lilly says peglispro is superior to Sanofi's Lantus
Medical Marketing and Media
Eli Lilly
Peglispro
basal insulin
Sanofi
Lantus
diabetes
insulin
Flag link:
Lilly peglispro delay may be boon for its biosimilar
Lilly peglispro delay may be boon for its biosimilar
Medical Marketing and Media
Eli Lilly
Peglispro
diabetes
basal insulin
biosimilars
Sanofi
Lantus
Flag link:
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro
Yahoo
Eli Lilly
diabetes
Peglispro
insulin
basal insulin
Flag link:
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Sanofi
Novo Nordisk
basal insulin
diabetes
Lantus
Levemir
Flag link: